{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T12:44:09Z","timestamp":1793882649862,"version":"4.7.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031478","name":"NextGenerationEU","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.nbd.2025.107150","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T22:26:03Z","timestamp":1760999163000},"page":"107150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Deep brain stimulation rescues the homeostasis disruption of circulating D- and L-amino acids level in men with Parkinson's disease"],"prefix":"10.1016","volume":"216","author":[{"given":"Tommaso","family":"Nuzzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Carrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Di Maio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Pizzella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Pietracupa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Modugno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Errico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Usiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2025.107150_bb0005","article-title":"Deep brain stimulation in Parkinson\u2019s disease: new and emerging targets for refractory motor and nonmotor symptoms","volume":"2017","author":"Anderson","year":"2017","journal-title":"Park. Dis."},{"key":"10.1016\/j.nbd.2025.107150_bb0010","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/mds.10543","article-title":"Body weight gain rate in patients with Parkinson\u2019s disease and deep brain stimulation","volume":"18","author":"Barichella","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.107150_bb0015","doi-asserted-by":"crossref","first-page":"E1050","DOI":"10.1210\/jc.2012-3838","article-title":"Deep brain stimulation of the subthalamic nucleus regulates postabsorptive glucose metabolism in patients with Parkinson\u2019s disease","volume":"98","author":"Batisse-Lignier","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.nbd.2025.107150_bb0020","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.neubiorev.2020.10.004","article-title":"The glutathione system in Parkinson\u2019s disease and its progression","volume":"120","author":"Bj\u00f8rklund","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.nbd.2025.107150_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fnana.2015.00091","article-title":"Oxidative stress and Parkinson\u2019s disease","volume":"9","author":"Blesa","year":"2015","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.nbd.2025.107150_bb0030","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2025.107150_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105697","article-title":"Striatal glutamatergic hyperactivity in Parkinson\u2019s disease","volume":"168","author":"Campanelli","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.107150_bb0040","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.tma.2019.09.001","article-title":"Amino acids in the regulation of aging and aging-related diseases","volume":"3","author":"Canfield","year":"2019","journal-title":"Transl. Med. Aging"},{"key":"10.1016\/j.nbd.2025.107150_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106698","article-title":"Multiomics approach discloses lipids and metabolites profiles associated to Parkinson\u2019s disease stages and applied therapies","volume":"202","author":"Carrillo","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.107150_bb0050","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/mds.20844","article-title":"International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson\u2019s disease: the NMSQuest study","volume":"21","author":"Chaudhuri","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.107150_bb0055","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10072-014-1921-3","article-title":"Montreal cognitive assessment (MoCA)-Italian version: regression based norms and equivalent scores","volume":"36","author":"Conti","year":"2015","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.nbd.2025.107150_bb0060","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12264-022-00934-6","article-title":"Parkinson\u2019s disease: a multisystem disorder","volume":"39","author":"Costa","year":"2023","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.nbd.2025.107150_bb0065","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1085\/jgp.201411302","article-title":"Glycine-dependent activation of NMDA receptors","volume":"145","author":"Cummings","year":"2015","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.nbd.2025.107150_bb0070","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0006-8993(92)91656-Y","article-title":"Presence of D-alanine in proteins of normal and Alzheimer human brain","volume":"592","author":"D\u2019Aniello","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2025.107150_bb0075","first-page":"57","article-title":"Expanding the repertoire of L-DOPA\u2019S actions: a comprehensive review of its functional neurochemistry. Prog. Neurobiol","volume":"151","author":"De Deurwaerd\u00e8re","year":"2017","journal-title":"Neurobiol. Neuropharmacol. Monoaminergic Syst."},{"key":"10.1016\/j.nbd.2025.107150_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106203","article-title":"Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson\u2019s disease patients","volume":"184","author":"Di Maio","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.107150_bb0085","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejphar.2016.05.009","article-title":"Glutamate in peripheral organs: biology and pharmacology","volume":"784","author":"Du","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2025.107150_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191670","article-title":"Serum amino acid profile in patients with Parkinson\u2019s disease","volume":"13","author":"Figura","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2025.107150_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174452","article-title":"Effect of the glycine transporter 1 inhibitor ALX-5407 on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset","volume":"910","author":"Frouni","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2025.107150_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175090","article-title":"Effect of glycine transporter 1 inhibition with bitopertin on parkinsonism and L-DOPA induced dyskinesia in the 6-OHDA-lesioned rat","volume":"929","author":"Frouni","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2025.107150_bb0105","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1017\/S1461145711001015","article-title":"D-serine adjuvant treatment alleviates behavioural and motor symptoms in Parkinson\u2019s disease","volume":"15","author":"Gelfin","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.nbd.2025.107150_bb0110","series-title":"Ultra-Performance Liquid Chromatography-Mass Spectrometry Analysis of Post-Mortem Brain Tissue Reveals Specific Amino Acid Profile Dysregulation in Parkinson\u2019s Disease and Alzheimer\u2019s Disease Patients","author":"Gervasoni","year":"2025"},{"key":"10.1016\/j.nbd.2025.107150_bb0115","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41531-025-01126-5","article-title":"Independent serum metabolomics approaches identify disrupted glutamic acid and serine metabolism in Parkinson\u2019s disease patients","volume":"11","author":"Gervasoni","year":"2025","journal-title":"Npj Park. Dis."},{"key":"10.1016\/j.nbd.2025.107150_bb0120","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.3389\/fneur.2019.01362","article-title":"Whole exome sequencing study of Parkinson disease and related Endophenotypes in the Italian population","volume":"10","author":"Gialluisi","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.nbd.2025.107150_bb0125","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13024-021-00455-2","article-title":"Identification of sixteen novel candidate genes for late onset Parkinson\u2019s disease","volume":"16","author":"Gialluisi","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2025.107150_bb0130","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement Disorder Society-sponsored revision of the unified Parkinson\u2019s disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.107150_bb0135","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13024-023-00676-7","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease \u2013 a key disease hallmark with therapeutic potential","volume":"18","author":"Henrich","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2025.107150_bb0140","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.bbr.2011.01.028","article-title":"Effects of D-cycloserine on MPTP-induced behavioral and neurological changes: potential for treatment of Parkinson\u2019s disease dementia","volume":"219","author":"Ho","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nbd.2025.107150_bb0145","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.3390\/nu15184023","article-title":"Aspartic acid in health and disease","volume":"15","author":"Hole\u010dek","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.nbd.2025.107150_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106413","article-title":"Blood D-serine levels correlate with aging and dopaminergic treatment in Parkinson\u2019s disease","volume":"192","author":"Imarisio","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.107150_bb0155","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","article-title":"Parkinson\u2019s disease: etiopathogenesis and treatment","volume":"91","author":"Jankovic","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2025.107150_bb0160","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1212\/WNL.0000000000003663","article-title":"Metabolomic biomarkers as strong correlates of Parkinson disease progression","volume":"88","author":"LeWitt","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2025.107150_bb0165","article-title":"Beyond the brain: exploring the multi-organ axes in Parkinson\u2019s disease pathogenesis","author":"Liu","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.nbd.2025.107150_bb0170","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/mds.10630","article-title":"Parkinson\u2019s disease patients with bilateral subthalamic deep brain stimulation gain weight","volume":"19","author":"Macia","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.107150_bb0175","first-page":"1192","article-title":"Specific roles of threonine in intestinal mucosal integrity and barrier function","volume":"3","author":"Mao","year":"2011","journal-title":"Front. Biosci. Elite Ed."},{"key":"10.1016\/j.nbd.2025.107150_bb0180","series-title":"Increase in Body Weight Is a Non-motor Side Effect of Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson\u2019s Disease","author":"Novakova","year":"2007"},{"key":"10.1016\/j.nbd.2025.107150_bb0185","doi-asserted-by":"crossref","first-page":"8898","DOI":"10.1038\/s41598-019-45419-1","article-title":"The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson\u2019s disease patients","volume":"9","author":"Nuzzo","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2025.107150_bb0190","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/mds.27115","article-title":"Past, present, and future of Parkinson\u2019s disease: a special essay on the 200th anniversary of the shaking palsy","volume":"32","author":"Obeso","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.107150_bb0195","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1007\/s12035-022-03203-9","article-title":"Common and rare variants in TMEM175 gene concur to the pathogenesis of Parkinson\u2019s disease in Italian patients","volume":"60","author":"Palomba","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2025.107150_bb0200","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.kjms.2012.02.010","article-title":"Potential of D-cycloserine in the treatment of behavioral and neuroinflammatory disorders in Parkinson\u2019s disease and studies that need to be performed before clinical trials","volume":"28","author":"Pawlak","year":"2012","journal-title":"Kaohsiung J. Med. Sci."},{"key":"10.1016\/j.nbd.2025.107150_bb0205","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2025.107150_bb0210","doi-asserted-by":"crossref","first-page":"16778","DOI":"10.1523\/JNEUROSCI.3041-12.2013","article-title":"Glycine Transporter-1 inhibition promotes striatal axon sprouting via NMDA receptors in dopamine neurons","volume":"33","author":"Schmitz","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.107150_bb0215","doi-asserted-by":"crossref","first-page":"7325","DOI":"10.3390\/ijms21197325","article-title":"Advances in D-amino acids in neurological research","volume":"21","author":"Seckler","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2025.107150_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.640603","article-title":"Analysis of genetic and non-genetic predictors of levodopa induced dyskinesia in Parkinson\u2019s disease","volume":"12","author":"Tirozzi","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.nbd.2025.107150_bb0225","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.biopsych.2005.06.032","article-title":"D-alanine added to antipsychotics for the treatment of schizophrenia","volume":"59","author":"Tsai","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2025.107150_bb0230","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/cne.21349","article-title":"Glycine receptors in the striatum, globus pallidus, and substantia nigra of the human brain: an immunohistochemical study","volume":"502","author":"Waldvogel","year":"2007","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2025.107150_bb0235","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2024.1507033","article-title":"Brain network and energy imbalance in Parkinson\u2019s disease: linking ATP reduction and \u03b1-synuclein pathology","volume":"17","author":"Watanabe","year":"2025","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.nbd.2025.107150_bb0240","article-title":"Metabolic effects of deep brain stimulation in Parkinson\u2019s disease \u2014 a systematic review and meta-analysis","volume":"0","author":"W\u0119grzynek-Gallina","year":"2025","journal-title":"Neurol. Neurochir. Pol."},{"key":"10.1016\/j.nbd.2025.107150_bb0245","series-title":"Differences in Sex and Genetic Status Affect the Disruption of NMDAR-Related Amino Acid Homeostasis in Parkinson\u2019s Disease","author":"Yahyavi","year":"2025"},{"key":"10.1016\/j.nbd.2025.107150_bb0250","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s12079-015-0315-5","article-title":"A pathway map of glutamate metabolism","volume":"10","author":"Yelamanchi","year":"2016","journal-title":"J. Cell Commun. Signal."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125003675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125003675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T02:28:13Z","timestamp":1763519293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996125003675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":50,"alternative-id":["S0969996125003675"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2025.107150","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.08.13.668904","asserted-by":"object"}]},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deep brain stimulation rescues the homeostasis disruption of circulating D- and L-amino acids level in men with Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2025.107150","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107150"}}